Camarda Financial Advisors’s Biogen BIIB Stock Holding History

Camarda Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,257	Closed	-$2.33M	–	105
2025 Q4	$2.33M	Buy	+13,257	New	+$2.17M	0.89%	39
2019 Q3	–	Sell	-10	Closed	-$2K	–	90
2019 Q2	$2K	Hold	10	–	–	﹤0.01%	313
2019 Q1	$2K	Buy	+10	New	+$3.15K	﹤0.01%	336
2018 Q4	–	Sell	-2,983	Closed	-$1.05M	–	168
2018 Q3	$1.05M	Sell	2,983 -81	-3%	-$27.9K	1.2%	19
2018 Q2	$889K	Buy	+3,064	New	+$861K	0.93%	26
2017 Q3	–	Sell	-4	Closed	-$1K	–	208
2017 Q2	$1K	Buy	+4	New	+$1.06K	﹤0.01%	218

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Camarda Financial Advisors's BIIB Position: Q1 2026 in Review

Camarda Financial Advisors sold out of Biogen (BIIB) in Q1 2026, closing a stake of 13,257 shares — an estimated $2.33M sold.

Camarda Financial Advisors first reported a position in BIIB in Q2 2017 and held it in 6 quarters. The position peaked at $2.33M in Q4 2025. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Camarda Financial Advisors reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
Camarda Financial Advisors sold 13,257 Biogen shares in Q1 2026, an estimated $2.33M.
Camarda Financial Advisors first reported a position in Biogen in Q2 2017 and held it in 6 quarters.
Camarda Financial Advisors's Biogen position peaked at $2.33M in Q4 2025.
1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Camarda Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.